2018 American Transplant Congress
Pre-Transplant Memory Patients Even without Detected Antibody Are at Rejection Risk in the First-Year after Heart Transplantation
Cedars Sinai Medical Center, Los Angeles.
Purpose: Patients (pts) with prior transplants, blood transfusions, and pregnancies awaiting heart transplantation (HTx) have potential to develop circulating anti-HLA antibodies (HLA Abs). Pts at…2018 American Transplant Congress
Effects of Health Literacy and Numeracy Literacy on Adherence, Quality of Life and Readiness to Transition in Pediatric Renal Transplant Recipients
Introduction: An adequate level of functional health literacy is essential for transplant recipients and caregivers to comprehend complex information and be adherent to recommendations. Given…2018 American Transplant Congress
Facial Allotransplantation: An Early Look at OPTN Data
Craniofacial Vascularized Composite Allograft (VCA) transplantation is a developing area in the field of transplantation. Thirteen craniofacial transplants have been performed in the US since…2018 American Transplant Congress
mTOR Inhibitor Based Immunosuppression Regimens Are Not Associated with Lower Risk for BK Infection
Introduction: BK virus continues to be a significant post-transplant complication with increasing incidence in the current era of potent immunosuppression. Mammalian target of rapamycin inhibitors…2018 American Transplant Congress
Using a Data Analytics Platform to Improve Patient Care in Pediatric Lung Transplantation
PurposeLung transplantation in children remains challenging, requiring extensive infrastructure and expertise. At our institution, we have performed 191 pediatric lung transplants since 2002. We hypothesized…2018 American Transplant Congress
Outcomes of Very Old Kidney Recipients of Grafts from Very Old Donors
Nephrology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
Aims: Describe the outcomes of very old kidney recipients of grafts from very old donors. Identify pretransplant clinical factors associated with graft and recipient survival.Methods:…2018 American Transplant Congress
No Deleterious Effect from the Presence of Donor Specific Antibodies (DSA) or Positive Flow Cytometry Crossmatch (FCXM) on the Outcomes of Simultaneous Liver-Kidney (SLK) Transplant Recipients
SLK transplant recipients have excellent outcomes that rival kidney alone recipients in terms of graft and patient survival and have better outcomes in terms of…2018 American Transplant Congress
Tissue Talks: Graft´s Histological Findings 10 Years after Belatacept or CNI
The BENEFIT study demonstrated that 7 yrs after kidney transplantation (KT), mean eGFR, patient and graft survival, were significantly higher in the belatacept group than…2018 American Transplant Congress
Humoral Immune Response to Seasonal Influenza Infection in Transplant Recipients
Background: Little is known about the serologic response to natural influenza infection in transplant recipients. We describe the hemagglutinin antibody response to influenza A/H1N1 infection…2018 American Transplant Congress
Significant Alteration in Transplant Center Performance Assessment with Extended Patient Follow Up Time
IntroductionCurrent transplant center performance models focus on 1-year graft and patient survival as primary outcomes. This is despite that 2.5 year cohorts are used to…
- « Previous Page
- 1
- …
- 102
- 103
- 104
- 105
- 106
- …
- 155
- Next Page »